POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 57 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,292,649 | +44.0% | 543,130 | +6.5% | 0.00% | – |
| Q2 2023 | $897,528 | +180.8% | 509,959 | +391.4% | 0.00% | – |
| Q1 2023 | $319,603 | -29.4% | 103,767 | +21.4% | 0.00% | – |
| Q4 2022 | $452,970 | +96.1% | 85,466 | +31.1% | 0.00% | – |
| Q3 2022 | $231,000 | +79.1% | 65,168 | +29.7% | 0.00% | – |
| Q2 2022 | $129,000 | -88.0% | 50,246 | -79.0% | 0.00% | – |
| Q1 2022 | $1,072,000 | -37.5% | 239,289 | -5.0% | 0.00% | – |
| Q4 2021 | $1,715,000 | -8.5% | 251,793 | -2.0% | 0.00% | – |
| Q3 2021 | $1,874,000 | -23.7% | 257,061 | +4.9% | 0.00% | – |
| Q2 2021 | $2,456,000 | +55.4% | 245,069 | +48.1% | 0.00% | – |
| Q1 2021 | $1,580,000 | -11.2% | 165,425 | +2.0% | 0.00% | – |
| Q4 2020 | $1,780,000 | +19.7% | 162,195 | -3.2% | 0.00% | – |
| Q3 2020 | $1,487,000 | – | 167,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |